MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 207 filers reported holding MEDIVATION INC in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $161,319,000 | +79.7% | 2,675,286 | +37.0% | 0.09% | +81.2% |
| Q1 2016 | $89,790,000 | -3.7% | 1,952,808 | +1.3% | 0.05% | +2.1% |
| Q4 2015 | $93,229,000 | -1.4% | 1,928,608 | -13.3% | 0.05% | 0.0% |
| Q3 2015 | $94,542,000 | -55.0% | 2,224,508 | +20.8% | 0.05% | -50.5% |
| Q2 2015 | $210,245,000 | -25.5% | 1,841,024 | -15.8% | 0.10% | -25.8% |
| Q1 2015 | $282,172,000 | -4.3% | 2,186,215 | -26.1% | 0.13% | -4.5% |
| Q4 2014 | $294,847,000 | -7.5% | 2,959,987 | -8.2% | 0.13% | -7.6% |
| Q3 2014 | $318,624,000 | -10.5% | 3,222,697 | -30.2% | 0.14% | -7.6% |
| Q2 2014 | $355,887,000 | +24.9% | 4,617,189 | +4.3% | 0.16% | +16.3% |
| Q1 2014 | $284,896,000 | +23.1% | 4,425,923 | +22.0% | 0.14% | +19.5% |
| Q4 2013 | $231,513,000 | +17.2% | 3,627,610 | +10.0% | 0.11% | +7.6% |
| Q3 2013 | $197,614,000 | +55.9% | 3,296,870 | +28.0% | 0.10% | +45.8% |
| Q2 2013 | $126,759,000 | – | 2,576,391 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |